MedTrace Logo

SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data

NCT06769646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110074

Last updated 2025-03-27

No results posted yet for this study

Summary

This study is being carried out in 4 countries (France, Italy, Spain and the UK) to understand the clinical care pathway of population living with type 2 diabetes who also have evidence of chronic kidney disease.

The primary objective is to describe the population with T2D and CKD in terms of demography, clinical characteristics and medication use by CKD stage.

Conditions

  • Type 2 Diabetes Mellitus (T2D) and Chronic Kidney Disease (CKD)

Interventions

OTHER

No tretament given

No treatment given

Sponsors & Collaborators

Principal Investigators

  • Clinical Transparency (dept. 2834) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-02
Primary Completion
2025-01-06
Completion
2025-01-06

Countries

  • India

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06769646 on ClinicalTrials.gov